Palatin Technologies Inc (PTN)

0.41
AMEX : Health Care
Prev Close 0.41
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.29 / 0.90
Avg Volume 1.28M
Exchange AMEX
Shares Outstanding 152.80M
Market Cap 67.23M
EPS -0.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Palatin Technologies Announces Closing Of License Agreement With AMAG Pharmaceuticals For North American Rights To Rekynda™

Will Also Report Second Quarter 2017 Results and Discuss Next Steps in its Development Programs

How to Trade Today's Most Active Stocks -- Ford, Palatin, More

How to Trade Today's Most Active Stocks -- Ford, Palatin, More

Here's a technical look at how to trade some of the most active stocks on the market right now.

Palatin Female Libido-Boosting Shot Fails Crucial Sex Frequency Test

Palatin Female Libido-Boosting Shot Fails Crucial Sex Frequency Test

Palatin appears be to playing a game of bait and switch with the design of its phase III studies.

Insider Trading Alert - AEL, PTN And BSX Traded By Insiders

Insider Trading Alert - AEL, PTN And BSX Traded By Insiders

Stocks with insider trader activity include AEL, PTN and BSX

Palatin Technologies (PTN) Stock Up After FDA Approval of 'Female Viagra'

Palatin Technologies (PTN) Stock Up After FDA Approval of 'Female Viagra'

Palatin Technologies (PTN) shares are rising after the FDA approved the first treatment for low female libido earlier this week.

Palatin Technologies (PTN) Stock Climbing on FDA Approval of 'Female Viagra'

Palatin Technologies (PTN) Stock Climbing on FDA Approval of 'Female Viagra'

Palatin Technologies (PTN) shares are climbing after the FDA approved the first low female libido treatment yesterday.

Palatin Technologies (PTN) Strong On High Relative Volume Today

Palatin Technologies (PTN) Strong On High Relative Volume Today

Trade-Ideas LLC identified Palatin Technologies (PTN) as a strong on high relative volume candidate

Palatin Technologies (PTN) Stock Spikes Following FDA Approval of 'Female Viagra' Treatment

Palatin Technologies (PTN) Stock Spikes Following FDA Approval of 'Female Viagra' Treatment

Palatin Technologies (PTN) shares are up over 30% after an FDA advisory panel voted to approve a version of the company's low female libido treatment.

3 Stocks Under $10 to Trade for Breakouts

3 Stocks Under $10 to Trade for Breakouts

These under-$10 stocks are within range of triggering breakout trades.

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the Drugs industry lower today.

Palatin Technologies, Inc. And PHT Corporation To Present On Best Practices In Female Sexual Dysfunction (FSD) Clinical Study Design At Managing ECOA Data Summit

Palatin Technologies, Inc. And PHT Corporation To Present On Best Practices In Female Sexual Dysfunction (FSD) Clinical Study Design At Managing ECOA Data Summit

Clinical Operations experts from Palatin Technologies, Inc. (NYSE MKT: PTN) and PHT Corporation will present on the effective use of eCOA Systems for clinical research on Female Sexual Dysfunction (FSD) at the...

Biotech Stock Mailbag: Amarin, MannKind, Palatin

Biotech Stock Mailbag: Amarin, MannKind, Palatin

Biotech columnist Adam Feuerstein answers readers' questions about health-care companies.

5 Stocks Poised for Breakouts

5 Stocks Poised for Breakouts

These stocks look ready to break out and trade higher from current levels.

Palatin Technologies' CEO Discusses F4Q12 Results - Earnings Call Transcript

Palatin Technologies' CEO Discusses F4Q12 Results - Earnings Call Transcript

Palatin Technologies' CEO Discusses F4Q12 Results - Earnings Call Transcript

Palatin Technologies' CEO Discusses F3Q2012 Results - Earnings Call Transcript

Palatin Technologies' CEO Discusses F3Q2012 Results - Earnings Call Transcript

Palatin Technologies' CEO Discusses F3Q2012 Results - Earnings Call Transcript

Palatin Technologies' CEO Discusses F2Q2012 Results - Earnings Call Transcript

Palatin Technologies' CEO Discusses F2Q2012 Results - Earnings Call Transcript

Palatin Technologies' CEO Discusses F2Q2012 Results - Earnings Call Transcript

Palatin Technologies CEO Discusses F1Q12 Results - Earnings Call Transcript

Palatin Technologies CEO Discusses F1Q12 Results - Earnings Call Transcript

Palatin Technologies CEO Discusses F4Q2011 Results - Earnings Call Transcript

Palatin Technologies CEO Discusses F4Q2011 Results - Earnings Call Transcript

Palatin Technologies CEO Discusses F3Q2011 Results - Earnings Call Transcript

Palatin Technologies CEO Discusses F3Q2011 Results - Earnings Call Transcript

Palatin Technologies CEO Discusses Q4 2010 Results - Earnings Call Transcript

Palatin Technologies CEO Discusses Q4 2010 Results - Earnings Call Transcript

Palatin Technologies CEO Discusses F1Q2011 Results - Earnings Call Transcript

Palatin Technologies CEO Discusses F1Q2011 Results - Earnings Call Transcript

Globecomm Systems - Upgrades & Downgrades

TheStreet Ratings released rating changes on 14 U.S. common stocks for September 29, 2010. Just four stocks were downgraded and 10 stocks have been upgraded by our stock model.

Palatin CEO Discusses F4Q2010 Results - Earnings Call Transcript

Palatin CEO Discusses F4Q2010 Results - Earnings Call Transcript

Bill Gross Buys Into Pimco Funds

Bill Gross increases holdings in three Pimco funds.

Palatin Technologies, Inc. F3Q10 (Qtr End 03/31/10) Earnings Call Transcript

Palatin Technologies, Inc. F3Q10 (Qtr End 03/31/10) Earnings Call Transcript

Friday's Health Winners & Losers

Merck climbs on settlement news.

Friday's Small-Cap Winners & Losers

ICU Medical cimbs on another share-buyback plan.

Thursday's Small-Cap Winners & Losers

Jo-Ann Stores falls on a per-share earnings miss.